About idursulfas e
Lysosomal enzyme replacement therapy
Used for
- Treats Hunter syndrome (mucopolysaccharidosis type II).
Usual adult dose
0.5 mg/kg by intravenous infusion once weekly.
Usual dose in children
0.5 mg/kg by intravenous infusion once weekly.
Common side effects
- Infusion reactions, including fever, rash, or breathing problems
- Headache
- Nausea
- High blood pressure
Important warnings
- Severe allergic reactions, including anaphylaxis, can occur during or after infusion.
- People with severe airway or lung disease may have greater risk of serious reactions.
- Infusions require monitoring and access to emergency treatment.
- Antibodies may reduce treatment response or increase infusion reactions.
Pregnancy
Human pregnancy information is limited; use only when clearly needed after weighing benefits and risks.
Breastfeeding
It is unknown whether idursulfase passes into breast milk; weigh treatment benefits against potential risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.